Altoona Center for Clinical Research   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Altoona PA United States (1987)

Organization Overview

First Clinical Trial
2005
NCT00281294
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Recruiting Altoona Center for Clinical Research | Recruiting Altoona Center for Clinical Research 1125 Old Rt 220 North Duncansville PA 16635 Phone 814-693-0300 Fax 814-693-0400

Active Ingredients

Drugs in Phase 3 Trials (2)

diclofenac (voltaren) (2 trials)

meloxicam (mobic) (1 trial)

Drugs in Phase 2 Trials (3)

fontolizumab (1 trial)

naltrexone (revia) (2 trials)

ngx267 (1 trial)

Drugs in Phase 1 Trials (2)

gimsilumab (1 trial)

pegsiticase (1 trial)

Drugs in Other Trials (3)

epicatechin (1 trial)

naproxen (naprosyn) (1 trial)

tj-14 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Hyperuricemia (Phase 1)

Osteoarthritis (Phase 3)

Sjogren's Syndrome (Phase 2)

Syndrome (Phase 2)

Xerostomia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 10